Adjuvant chemotherapy versus concurrent chemoradiotherapy for high-risk cervical cancer after radical hysterectomy and systematic lymphadenectomy

@article{Takekuma2016AdjuvantCV,
  title={Adjuvant chemotherapy versus concurrent chemoradiotherapy for high-risk cervical cancer after radical hysterectomy and systematic lymphadenectomy},
  author={Munetaka Takekuma and Yuka Kasamatsu and Nobuhiro Kado and Shiho Kuji and Aki Tanaka and Nobutaka Takahashi and Masakazu Abe and Yasuyuki Hirashima},
  journal={International Journal of Clinical Oncology},
  year={2016},
  volume={21},
  pages={741-747}
}
The aims of this study were to evaluate the efficacy and toxicity of chemotherapy (CT) compared with concurrent chemoradiotherapy (CCRT) after radical hysterectomy and lymphadenectomy in high-risk patients with early-stage cervical cancer and to evaluate whether the radicality of the lymphadenectomy would affect the outcome and toxicity of postoperative adjuvant therapy. The cases of all patients (n = 393) with FIGO IB1–IIB cervical cancer who were treated by radical surgery at Shizuoka Cancer… CONTINUE READING